AHWP identifies areas for medtech regulatory convergence under 2020 strategic plan
This article was originally published in Clinica
The Asian Harmonization Working Party has identified ten areas where it believes there is "most potential for success" in harmonising the medtech regulatory requirements of its 23 member economies.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.